Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
8703266
Reference Type
Journal Article
Title
Inhibitors of cholesterol synthesis and myelin formation
Author(s)
Smith, ME; Hasinoff, CM; Fumagalli, R
Year
1970
Is Peer Reviewed?
1
Journal
Lipids
ISSN:
0024-4201
EISSN:
1558-9307
Volume
5
Issue
8
Page Numbers
665-671
Language
English
DOI
10.1007/BF02531432
Abstract
Inhibitors of cholesterol biosynthesis AY 9944 and 20,25 diazacholesterol were administered by stomach tube to suckling rats in varying doses during the time of rapid myelination (15-22 days of age). Purified myelin was prepared from the brains and spinal cords, and the sterol content analyzed. Up to 50% of the myelin sterol consisted of desmosterol in rats treated with 20,25 diazacholesterol, while 7-dehydrocholesterol comprised at least one third of the myelin sterol in rats administered AY 9944. Myelin from rats treated with both compounds contained desmosterol, 7-dehydrocholesterol, Δ5,7,24 cholestatriene-3-β-ol and an unknown sterol, the four comprising about 45% of the total sterol. The proportion of phospholipid: galactolipid-total sterol in myelin from the drug-treated rats was not significantly different from the normal, although much less myelin was recovered. Brain and spinal cord slices from 22 to 25-day rats pretreated with inhibitors showed decreased uptake of U-14C-glucose into all myelin components. The decreased uptake was approximately proportional in all lipids and the protein was also affected. It is proposed that myelin composition is fixed, and that a deficiency of one of the lipid components will limit the assembly of the whole lipid portion of the membrane. 1969 American Oil Chemists' Society.
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity